Squamous cell carcinoma
MONDO:0005096A carcinoma arising from squamous epithelial cells. Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells. Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated. Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells. Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.
Also known as: carcinoma, squamous cell, malignant, epidermoid carcinoma, epidermoid cell cancer, malignant epidermoid cell neoplasm, malignant epidermoid cell tumor, malignant epidermoid cell tumour, malignant squamous cell neoplasm, malignant squamous cell tumor
4409 clinical trials for this condition and its sub-types, 177 tagged with Squamous cell carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Squamous cell carcinoma
-
Head and neck squamous cell carcinoma 831 trials · 1,057 incl. sub-types
13 sub-types
- Pharyngeal squamous cell carcinoma 5 trials · 203 incl. sub-types Sub-types →
- Lip and oral cavity squamous cell carcinoma 21 trials · 159 incl. sub-types Sub-types →
- Laryngeal squamous cell carcinoma 72 trials · 77 incl. sub-types Sub-types →
- Nasal cavity and paranasal sinus squamous cell carcinoma 9 trials · 13 incl. sub-types Sub-types →
- Nasopharyngeal squamous cell carcinoma 12 trials
- Paranasal sinus squamous cell carcinoma 11 trials Sub-types →
- Nasal cavity squamous cell carcinoma 6 trials
- External ear squamous cell carcinoma 1 trial
- Conjunctival squamous cell carcinoma 0 trials
- Cornea squamous cell carcinoma 0 trials
- Lacrimal gland squamous cell carcinoma 0 trials
- Middle ear squamous cell carcinoma 0 trials
- Primary intraosseous squamous cell carcinoma 0 trials
-
Esophageal squamous cell carcinoma 306 trials · 307 incl. sub-types
4 sub-types
- Esophageal adenosquamous carcinoma 3 trials
- Undifferentiated carcinoma of esophagus 1 trial
- Esophageal basaloid carcinoma 0 trials
- Esophagus verrucous carcinoma 0 trials
-
Skin squamous cell carcinoma 151 trials · 158 incl. sub-types
9 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Anal margin squamous cell carcinoma 4 trials
- Acantholytic squamous cell skin carcinoma 1 trial
- Clear cell squamous cell skin carcinoma 1 trial
- Sarcomatoid squamous cell skin carcinoma 1 trial
- Plantar verrucous skin carcinoma 0 trials
- Pseudovascular skin squamous cell carcinoma 0 trials
- Skin adenosquamous carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
-
Squamous cell lung carcinoma 66 trials · 146 incl. sub-types
2 sub-types
- Non-small cell squamous lung carcinoma 84 trials · 89 incl. sub-types Sub-types →
- Lung occult squamous cell carcinoma 0 trials
-
Human papillomavirus-related squamous cell carcinoma 115 trials · 116 incl. sub-types
1 sub-type
-
Colorectal squamous cell carcinoma 1 trial · 54 incl. sub-types
3 sub-types
- Squamous cell carcinoma of rectum 8 trials · 53 incl. sub-types Sub-types →
- Colorectal adenosquamous carcinoma 0 trials Sub-types →
- Squamous cell carcinoma of colon 0 trials Sub-types →
-
Adenosquamous carcinoma 8 trials · 45 incl. sub-types
15 sub-types
- Cervical adenosquamous carcinoma 16 trials Sub-types →
- Pancreatic adenosquamous carcinoma 13 trials
- Adenosquamous lung carcinoma 5 trials
- Esophageal adenosquamous carcinoma 3 trials
- Endometrial adenosquamous carcinoma 2 trials
- Bartholin gland adenosquamous carcinoma 0 trials
- Adenosquamous breast carcinoma 0 trials
- Adenosquamous prostate carcinoma 0 trials
- Colorectal adenosquamous carcinoma 0 trials Sub-types →
- Gallbladder adenosquamous carcinoma 0 trials
- Gastric adenosquamous carcinoma 0 trials
- Liver adenosquamous carcinoma 0 trials Sub-types →
- Salivary gland adenosquamous carcinoma 0 trials
- Skin adenosquamous carcinoma 0 trials
- Thymic adenosquamous carcinoma 0 trials
-
Cervical squamous cell carcinoma 36 trials · 40 incl. sub-types
7 sub-types
- Cervical adenosquamous carcinoma 16 trials Sub-types →
- Cervical basaloid carcinoma 0 trials
- Cervical keratinizing squamous cell carcinoma 0 trials
- Cervical lymphoepithelioma-like carcinoma 0 trials
- Cervical non-keratinizing squamous cell carcinoma 0 trials
- Cervical verrucous carcinoma 0 trials
- Microinvasive cervical squamous cell carcinoma 0 trials
-
Metastatic squamous cell carcinoma 39 trials
-
Squamous cell carcinoma of penis 21 trials · 29 incl. sub-types
5 sub-types
-
Vulvar squamous cell carcinoma 22 trials
6 sub-types
- Bartholin gland squamous cell carcinoma 0 trials Sub-types →
- Vulva verrucous carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
- Vulvar keratoacanthoma-like carcinoma 0 trials
- Vulvar non-keratinizing squamous cell carcinoma 0 trials
-
Squamous cell carcinoma of pancreas 3 trials · 13 incl. sub-types
1 sub-type
- Pancreatic adenosquamous carcinoma 13 trials
-
Bone squamous cell carcinoma 0 trials · 11 incl. sub-types
1 sub-type
-
Squamous carcinoma in situ 5 trials · 10 incl. sub-types
3 sub-types
- Skin squamous cell carcinoma in situ 4 trials · 6 incl. sub-types Sub-types →
- Penis carcinoma in situ 1 trial
- Trachea carcinoma in situ 0 trials
-
Vaginal squamous cell carcinoma 8 trials
-
Bladder squamous cell carcinoma 5 trials
2 sub-types
- Bladder urachal squamous cell carcinoma 0 trials
- Bladder verrucous carcinoma 0 trials
-
Basaloid squamous cell carcinoma 2 trials · 5 incl. sub-types
7 sub-types
- Anus basaloid carcinoma 3 trials
- Basaloid carcinoma of the penis 0 trials
- Cervical basaloid carcinoma 0 trials
- Esophageal basaloid carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
- Thymic basaloid carcinoma 0 trials
- Vulvar basaloid squamous cell carcinoma 0 trials
-
Gastric squamous cell carcinoma 4 trials
1 sub-type
- Gastric adenosquamous carcinoma 0 trials
-
Papillary squamous carcinoma 1 trial · 4 incl. sub-types
2 sub-types
- Verrucous carcinoma 0 trials · 3 incl. sub-types Sub-types →
- Papillary carcinoma of the penis 0 trials Sub-types →
-
Ovarian squamous cell carcinoma 2 trials
-
Urethra squamous cell carcinoma 2 trials
1 sub-type
- Urethral verrucous carcinoma 0 trials
-
Endometrial squamous cell carcinoma 0 trials · 2 incl. sub-types
1 sub-type
- Endometrial adenosquamous carcinoma 2 trials
-
Scrotum squamous cell carcinoma 1 trial
-
1 sub-type
-
Ureter squamous cell carcinoma 1 trial
-
Keratinizing squamous cell carcinoma 0 trials · 1 incl. sub-types
8 sub-types
- Acantholytic squamous cell skin carcinoma 1 trial
- Clear cell squamous cell skin carcinoma 1 trial
- Sarcomatoid squamous cell skin carcinoma 1 trial
- Cervical keratinizing squamous cell carcinoma 0 trials
- Large cell keratinizing variant squamous cell breast carcinoma 0 trials
- Pseudovascular skin squamous cell carcinoma 0 trials
- Skin basaloid carcinoma 0 trials
- Vulvar keratinizing squamous cell carcinoma 0 trials
-
Gallbladder squamous cell carcinoma 0 trials
1 sub-type
- Gallbladder adenosquamous carcinoma 0 trials
-
Prostate squamous cell carcinoma 0 trials
1 sub-type
- Adenosquamous prostate carcinoma 0 trials
-
Renal pelvis squamous cell carcinoma 0 trials
-
Sarcomatoid squamous cell carcinoma 0 trials
2 sub-types
-
Squamous cell breast carcinoma 0 trials
4 sub-types
-
2 sub-types
- Liver adenosquamous carcinoma 0 trials Sub-types →
- Squamous cell bile duct carcinoma 0 trials Sub-types →
-
Thymus squamous cell carcinoma 0 trials
2 sub-types
- Thymic adenosquamous carcinoma 0 trials
- Thymic basaloid carcinoma 0 trials
-
Trachea squamous cell carcinoma 0 trials
1 sub-type
- Trachea carcinoma in situ 0 trials
Most studied deeper sub-types
-
Could a Telomere-Targeting drug revive immunotherapy in lung cancer?
Disease control OngoingThis phase 2 trial tests a new drug called THIO, which targets telomeres in cancer cells, followed by the immunotherapy cemiplimab (LIBTAYO) in people with advanced non-small cell lung cancer. The study includes about 227 participants whose cancer has progressed after initial tre…
Phase 2 • Sponsor: Maia Biotechnology • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Virus therapy joins Chemo-Radiation in fight against esophageal cancer
Disease control OngoingThis early-phase trial tests whether adding a cancer-killing virus called OBP-301 to standard chemotherapy and radiation is safe for people with advanced esophageal or gastroesophageal cancer who cannot have surgery. The virus is designed to infect and destroy tumor cells. Sixtee…
Phase 1 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can Pre-Surgery immunotherapy prime the immune system to fight head and neck cancer?
Disease control OngoingThis phase II trial is investigating whether giving immunotherapy before surgery can boost the immune system's attack on head and neck squamous cell carcinoma. Participants receive atezolizumab alone or combined with other immune-modulating agents, then undergo surgery. The study…
Phase 2 • Sponsor: Alain Algazi • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Immunotherapy before surgery may cut skin cancer recurrence
Disease control OngoingThis trial tests whether giving the immunotherapy drug pembrolizumab (Keytruda) before surgery can improve outcomes for people with high-risk cutaneous squamous cell carcinoma (cSCC), a common skin cancer. Participants receive pembrolizumab infusions before their planned surgery,…
Phase 2 • Sponsor: Diwakar Davar • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Immunotherapy before surgery shows promise for head and neck cancer
Disease control OngoingThis phase II trial is testing whether giving the immunotherapy drug cemiplimab before surgery can help shrink tumors in people with stage II to IV head and neck skin cancer that can be removed. The study enrolled 44 participants and aims to see how many respond to the drug. If i…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New combo therapy offers hope for head and neck cancer patients who Can't take standard chemo
Disease control OngoingThis phase 2 trial tests a weekly combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy pembrolizumab in 31 patients with metastatic head and neck cancer who cannot receive the standard drug 5-fluorouracil. The goal is to see if this regimen sh…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Could less radiation be enough for HPV throat cancer?
Disease control OngoingThis study compares a reduced dose of radiation therapy combined with the immunotherapy drug nivolumab against the standard treatment of full-dose radiation plus cisplatin for early-stage HPV-positive oropharyngeal cancer in non-smokers. About 384 participants are enrolled to see…
Phase 2/3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug hope for advanced skin cancer patients
Disease control OngoingThis study tests whether the drug afatinib can shrink tumors in people with advanced cutaneous squamous cell carcinoma (a type of skin cancer) that cannot be treated with surgery or radiation. About 25 adults with adequate organ function will receive afatinib, and researchers wil…
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New radiation treatment shows promise for tough skin cancers
Disease control OngoingThis study tests a new type of radiation therapy, called DaRT, for people with recurrent squamous cell skin cancer that has not responded to standard treatments. About 86 participants will receive the treatment directly into their tumors. The main goals are to see if the tumors s…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail shows promise in battling advanced head and neck cancer
Disease control OngoingThis study tests whether adding two drugs, niraparib and dostarlimab, to standard radiation therapy can better control advanced head and neck cancer. About 34 adults with stage III or IV cancer will receive the drugs before, during, and after radiation. The goal is to see if this…
Phase 1/2 • Sponsor: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Immune cell therapy shows promise for tough cancers
Disease control OngoingThis phase 2 study tests a personalized immune cell therapy called tumor-infiltrating lymphocytes (TIL) in 20 people with advanced solid cancers (like stomach, colon, or pancreatic cancer) that have not responded to standard treatments. Patients first receive chemotherapy to prep…
Phase 2 • Sponsor: Udai Kammula • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Immunotherapy duo shows promise against advanced oral cancer
Disease control OngoingThis study tests whether giving two immunotherapy drugs (tiragolumab and atezolizumab) before and after standard surgery and chemoradiation can help control advanced oral cancer. It includes 29 adults with newly diagnosed, stage 3-4 oral cavity squamous cell carcinoma that has a …
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New combo therapy aims to shrink inoperable skin cancers
Disease control OngoingThis phase 2 trial is testing whether combining radiation therapy with the immunotherapy drug cemiplimab can effectively treat locally advanced skin cancer that cannot be surgically removed. The study involves 34 participants who will receive both treatments over about 12 months.…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New proton therapy may reduce side effects in esophageal cancer treatment
Disease control OngoingThis study compares two radiation methods—proton beam therapy and standard intensity-modulated radiation therapy—for people with esophageal cancer. Both are given alongside chemotherapy. The goal is to see if the newer proton therapy is safer and more effective at controlling the…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could less radiation be just as effective for HPV throat cancer?
Disease control OngoingThis study compares a lower dose of radiation to the standard dose for people with HPV-positive throat cancer. The goal is to see if the lower dose can control the cancer just as well while causing fewer side effects. The trial involves 23 participants with advanced but non-sprea…
Phase 3 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Radioactive seeds zapped tumors from inside – early trial shows promise
Disease control OngoingThis study is testing a device called DaRT that delivers alpha radiation directly into tumors. It is for people with skin cancer, mouth tumors, or superficial soft tissue sarcoma who have not responded to other treatments or cannot have standard therapy. The goal is to see if the…
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a Chemo-Immunotherapy cocktail spare head and neck cancer patients from radiation?
Disease control OngoingThis phase 2 trial tests a combination of two chemotherapy drugs (carboplatin and nab-paclitaxel) plus an immunotherapy drug (durvalumab) given before surgery for people with locally advanced head and neck cancer. The goal is to shrink or eliminate the tumor so that radiation—whi…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New drug combo aims to reboot immune attack on head and neck cancer
Disease control OngoingThis phase 2 trial tests whether adding bavituximab to pembrolizumab can help people with advanced head and neck cancer whose tumors have stopped responding to standard immunotherapy. The study enrolled 7 participants and measures how many tumors shrink or disappear. The goal is …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New shot shows promise against tough skin cancer
Disease control OngoingThis study tests a new drug combination (pembrolizumab plus berahyaluronidase alfa) given as a shot under the skin for Japanese patients with advanced squamous cell skin cancer that has spread or cannot be removed by surgery. The main goal is to see if the treatment can shrink tu…
Phase 2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to improve head and neck cancer outcomes
Disease control OngoingThis study tests whether adding two drugs, pembrolizumab and olaparib, before and after standard chemoradiation can help control locally advanced head and neck cancer. About 45 adults with this cancer will receive the drug combination. The main goal is to see if this approach imp…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blue dye gel shows promise for treating inoperable skin cancer
Disease control By invitation onlyThis study tests whether a special blue dye gel (methylene blue) can safely shrink skin cancer tumors and help wounds heal in people who cannot have surgery or radiation. About 20 adults with advanced squamous cell carcinoma will apply the gel every two days for a month, followed…
Phase 3 • Sponsor: Daryoush Hamidi Alamdari, PhD • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New injection could shrink skin cancer before surgery
Disease control OngoingThis study tests an experimental drug called RP1 that is injected directly into skin cancer tumors. The goal is to see if it can shrink or eliminate the cancer before surgery. Up to 12 adults with a type of skin cancer called cutaneous squamous cell carcinoma will take part. The …
Phase 1/2 • Sponsor: Sherrif Ibrahim • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Weekly vs. Every-3-Week cisplatin: which is safer for head and neck cancer?
Disease control OngoingThis phase 2 trial tests whether giving cisplatin chemotherapy weekly alongside radiation causes fewer severe side effects than the standard every-3-week schedule in people with head and neck cancer. About 80 participants will receive one of the two schedules. The study also look…
Phase 2 • Sponsor: Susanne Arnold • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Laser microscope may speed up skin cancer diagnosis
Diagnosis OngoingThis trial is testing whether a special laser microscope can quickly and accurately examine skin lesions, including benign tumors, basal cell carcinoma, melanoma, and squamous cell cancer. The goal is to see if this technique can determine the extent, structure, and type of a ski…
Sponsor: LMU Klinikum • Aim: Diagnosis
Last updated Aug 28, 2026 00:00 UTC
-
New imaging method could help doctors map skin tumors in 3D
Diagnosis PausedThis study tests a special camera that uses light and sound to take 3D pictures of skin cancer. The goal is to see how deep and wide a tumor is before surgery. About 200 people with suspected skin cancer will take part. The images will be compared to standard lab results to see i…
Sponsor: Region Skane • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
AI app aims to catch deadly skin cancer early in rare disease patients
Diagnosis OngoingThis study is developing an artificial intelligence app to detect squamous cell carcinoma (a type of skin cancer) in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic blistering condition. Twenty adults with RDEB and a history of skin cancer will submi…
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Mouth rinse could ease painful radiation side effects for head and neck cancer patients
Symptom relief OngoingThis trial tests Gelclair, a mouth rinse that forms a protective coating over the mouth's lining, to see if it eases the painful mouth sores (oral mucositis) caused by radiation therapy for head and neck cancer. The study enrolls adults with squamous cell carcinoma who will recei…
Phase 4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
New drug aims to spare cancer patients from debilitating mouth sores
Symptom relief OngoingThis phase 2 trial tests whether the drug RRx-001 can prevent severe oral mucositis (painful mouth sores) in 216 patients with head and neck cancer receiving standard chemoradiation. Patients are randomly assigned to receive RRx-001 or a placebo alongside their usual treatment. T…
Phase 2 • Sponsor: EpicentRx, Inc. • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Could a phone call replace the clinic visit for throat cancer Follow-Up?
Symptom relief OngoingThis study compares standard in-person follow-up care with telemedicine (phone or video visits) for people who have finished treatment for HPV-related throat cancer and show no signs of cancer on scans. The goal is to see which approach better maintains quality of life, detects a…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Robotic surgery or radiation? new study compares which is better for throat cancer patients' quality of life
Symptom relief OngoingThis study compares two treatments for early-stage throat cancer: robotic surgery (TORS) or radiation therapy (IMRT). It looks at which one leads to better swallowing function and overall quality of life. About 138 adults with HPV-related throat cancer are taking part. The goal i…
Sponsor: Christian von Buchwald • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New study examines immunotherapy outcomes in american indian cancer patients
Knowledge-focused OngoingThis study reviews medical records of 72 American Indian patients treated with immunotherapy for cancers like lung cancer, melanoma, and kidney cancer. Researchers compare their outcomes—such as how long the cancer is controlled and side effects—to those of White patients. The go…
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Sep 20, 2026 00:00 UTC
-
Brooklyn study tests if a free seminar can save lives from melanoma
Knowledge-focused OngoingThis pilot study tests whether a community-based educational seminar can improve knowledge about melanoma and skin cancer. About 45 adults in Brooklyn will attend a session led by a community health worker and complete surveys over 12 months. The goal is to see if people learn mo…
Sponsor: NYU Langone Health • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC
-
Scientists build atlas of Pre-Cancerous lung lesions to stop cancer before it starts
Knowledge-focused OngoingThis study collects tissue samples from 240 adults with lung spots that may turn into cancer. Researchers will analyze these samples to create a detailed map of early changes in the lungs. The goal is to better understand how lung cancer develops and find ways to prevent it.
Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Mini-Device implanted in tumors could reveal which drug works best
Knowledge-focused By invitation onlyThis early-phase study tests a tiny implantable device that delivers very small amounts of several approved cancer drugs directly into skin cancer tumors. The goal is to see if the device can safely and effectively identify which drug triggers the most cancer cell death in that s…
Early phase 1 • Sponsor: Oliver Jonas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Could a DNA swab after surgery predict Cancer's return?
Knowledge-focused OngoingThis study looks at whether testing the surgical wound for leftover tumor DNA can help predict if oral cancer will come back. Researchers will check for this DNA in 31 patients after their tumor is removed. The goal is to see if this test gives useful information beyond standard …
Sponsor: Centre Henri Becquerel • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
New screening could open door to T-Cell therapy for Hard-to-Treat cancers
Knowledge-focused OngoingThis study screens up to 1,150 people with advanced solid tumors like head and neck, cervical, or lung cancer. Researchers test blood and tumor samples to see if participants have the right genetic markers for future T-cell therapy trials. The goal is to find who might benefit fr…
Sponsor: TScan Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC